This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated PLK4 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PLK4 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~109 kDa | |
| Gel | 8–10% (standard starting point) | |
| Positive control | Testis (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 3 isoform(s) |
The A01947 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | extracts of various cell lines, (catalog A01947) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | Blocking buffer: 3% nonfat dry milk in TBST (catalog A01947) |
| Primary antibody | A01947 · 1:1000 (catalog A01947) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Goat Anti-Rabbit IgG, 1:10000 (catalog A01947) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL (catalog A01947) |
PLK4 has a predicted 109 kDa monomer; homodimerization and isoforms could affect bands, but their migration effects are unverified and no empirical band is supplied.
| Band near 109 kDa | consistent with the predicted PLK4 monomer size; migration is unverified |
| Band near 218 kDa under nonreducing conditions | could reflect the reported homodimer |
| Several bands at different sizes | could reflect isoforms 1, 2, and 3; distinct migration is unverified |
| Band in a centrosome-enriched fraction | consistent with PLK4 localization at the centrosome |
| Predicted monomer mass | sets a 109 kDa reference, not a measured migration position |
| Homodimer by similarity | could yield a band near twice the monomer size under nonreducing or incompletely reducing conditions |
| Isoforms 1, 2, and 3 | could differ in size, but their masses and migration differences are not supplied |
| Phosphoserines at residues 401, 665, and 817 | are documented modifications without a demonstrated band shift |
| N6-acetyllysines at residues 45 and 46 | are documented modifications without a demonstrated band shift |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | PLK4 localization at centrioles may limit its representation in whole-cell lysate | check a centrosome-enriched fraction and a PLK4-positive control |
| Band higher than expected | reported homodimer may persist with incomplete reduction | compare reducing and nonreducing preparations and verify band identity |
| Band lower than expected | an alternative isoform is possible, but its migration is unknown | check antibody epitope coverage and verify band identity |
| Multiple bands | isoforms 1, 2, and 3 are annotated, but distinct bands are unverified | compare isoform-aware controls and verify each band's identity |
| Weak or no signal | PLK4 may be poorly represented in the sampled fraction | check a centrosome-enriched fraction and a PLK4-positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Testis | elongated or late spermatids | High | Protein (IHC) | HPA → |
| Appendix | glandular cells | Medium | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Medium | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Medium | Protein (IHC) | HPA → |
| Cervix | glandular cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
| Caudate | glial cells | Not detected | Protein (IHC) | HPA → |
| Cerebellum | cells in granular layer | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for PLK4, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
the supplier A01947 is an anti-PLK4 antibody listed for human, mouse and rat. Its Western blot image uses cell-line extracts at 25 µg per lane and a 1:1000 primary dilution; the supplied caption does not identify the cell lines or document species-specific validation.
Which to pick: A01947 is the only listed option and has a Western blot image. Use the reported 1:1000 primary dilution as a starting point, and confirm performance in your own sample.